Skip navigationAccessibility Quick Key Guide
Subscribe/Renew      Help      Feedback & User Surveys      About  
American Psychiatric Publishing, Inc.
Log In  

< Go back *Tips for better searches

PsychiatryOnline topic: antipsychotic agents

  Book Results (205)   Journal Results (2000)   Guideline Results (36)
Journal Results (2000)
Guideline Results (36)


Book Results (205) >
Limit book results by topic:

antipsychotic agents >
– absorption
– in acquired immunodeficiency syndrome
– in acute stress disorder
– administration
– in adolescent patients
– adrenergic effects
– adverse effects
– aggression and
– aggressive behavior and
– agitation and
– in alzheimer's disease
– anticholinergic effects
– antidepressants and
– attention deficit/hyperactivity disorder and
– in bipolar disorder
– bipolar disorder and
– blood levels
– in borderline personality disorder
– borderline personality disorder and
– carbamazepine and
– cardiac effects
– cardiovascular effects
– chemical structure
– chemical structures
– in child and adolescent psychiatry
– choice of
– clinical trials
– clinical trials in the elderly
– clinical use
– complications
– conduct disorder and
– costs
– in delirium
– dementia and
– depot
– dermatologic effects
– in development
– discontinuation
– distribution
– dosage
– dose-response curves
– drug augmentation for
– drug interactions
– drug interactions
– drug metabolism
– drug-drug interactions
– in early inpatient treatment
– early-onset schizophrenia and
– efficacy
– in elderly patients
– endocrine effects
– excretion
– extrapyramidal effects
– follow-up
– formulations
– future developments
– generalized anxiety disorder and
– geriatric
– geriatric bipolar disorder and
– geriatric delusional disorder and
– geriatric dosage
– geriatric drug response
– in geriatric psychiatry
– geriatric schizophrenia and
– hematologic effects
– hepatic effects
– historical background
– historical development
– in hiv
– indications
– informed consent for
– intermittent explosive disorder and
– lactaction and
– lactation and
– lithium versus
– long-acting injectable
– low potency vs. high potency
– maintenance therapy
– mechanism of action
– medication switch and
– mental retardation and
– metabolic effects
– metabolism
– monitoring
– mood stabilizers and
– mortality
– multiple personality disorder and
– neurotransmitter receptors and
– in obsessive-compulsive disorder
– ocd and
– ocular effects
– oxcarbazepine and
– in panic disorder
– pediatric
– pediatric aids and
– pediatric anxiety and
– pediatric bipolar disorder and
– pediatric insomnia and
– in pediatric patients
– pharmacodynamics
– pharmacokinetics
– pharmacological effects
– pharmacology
– in post-traumatic stress disorder
– potency
– in pregnancy
– pregnancy and
– pretreatment evaluation
– in psychiatric emergencies
– ptsd and
– risk factors
– in schizophrenia
– schizophrenia and
– seizure threshold effects
– selection
– sexual dysfunction and
– sexual dysfunction and
– side effects
– strength
– structure-activity relations
– suicidal behavior and
– suicide prevention and
– tardive dyskinesia and
– temperature regulation effects
– in the elderly
– tic disorders and
– tourette's syndrome and
– toxicity
– toxicology
– violence and
– weight gain and

1-20 of 205 Book Results Next Results >


1. Antipsychotic Medications
Textbook of Psychiatry > Chapter 26. Psychopharmacology


2. Table 3. Second-Generation Antipsychotics
APA Practice Guidelines > TREATING ALZHEIMER’S DISEASE AND OTHER DEMENTIAS: A Quick Reference Guide > F. Implementation of Pharmacological Treatments > In general, use low starting doses, small dose increases, and long intervals between dose increases.


3. 1. Antipsychotic Medications
APA Practice Guidelines > TREATING DELIRIUM: A Quick Reference Guide > D. Specific Somatic Interventions


4. 1. Antipsychotics
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias, Second Edition > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > C. Development and Implementation of a Stage-Specific Treatment Plan > 5. Implementation of Pharmacological Treatments > b. Treatments for Psychosis and Agitation


5. 1. Efficacy
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias, Second Edition > Part B. Background Information and Review of Available Evidence > V. Review of Available Evidence > B. Somatic Treatments > 2. Treatments for Psychosis and Agitation > a. Antipsychotics


6. 1. Somatic Therapies
APA Practice Guidelines > ASSESSING AND TREATING SUICIDAL BEHAVIORS: A Quick Reference Guide > C. Specific Treatment Modalities


7. 1. Antipsychotic medications
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments


8. 2. Side effects and toxicity
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias, Second Edition > Part B. Background Information and Review of Available Evidence > V. Review of Available Evidence > B. Somatic Treatments > 2. Treatments for Psychosis and Agitation > a. Antipsychotics


9. 2. Antipsychotic medications
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With HIV/AIDS > PART B: Review and Synthesis of Available Evidence > VI. Data Regarding Psychiatric Treatments for Individuals With HIV Infection > B. Pharmacologic Treatment


10. 3. Use of Antipsychotic Medications in the Acute Phase
APA Practice Guidelines > TREATING SCHIZOPHRENIA: A Quick Reference Guide > B. Acute Phase


11. 3. Use of antipsychotic medications in the acute phase
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part A: Treatment Recommendations for Patients With Schizophrenia > II. Formulation and Implementation of a Treatment Plan > B. Acute Phase


12. 3. Use of antipsychotic medications in the stable phase
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part A: Treatment Recommendations for Patients With Schizophrenia > II. Formulation and Implementation of a Treatment Plan > D. Stable Phase


13. 4. Antipsychotic agents
APA Practice Guidelines > Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors > Part A: Assessment, Treatment, and Risk Management Recommendations > IV. Specific Treatment Modalities > A. Somatic Therapies


14. 5. Antipsychotics
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Medications


15. 5. Antipsychotic medications
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > D. Maintenance Treatment


16. 6. Antipsychotics
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > B. Somatic Treatments of Acute Depressive Episodes


17. 7. Neuroleptics
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments


18. a. Antipsychotics
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias, Second Edition > Part B. Background Information and Review of Available Evidence > V. Review of Available Evidence > B. Somatic Treatments > 2. Treatments for Psychosis and Agitation


19. Augmenting an SRI with an antipsychotic medication
APA Practice Guidelines > TREATING OBSESSIVE-COMPULSIVE DISORDER: A Quick Reference Guide > D. Changing Treatment > D. Changing Treatment


20. b) Efficacy
APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 7. Neuroleptics


1-20 of 205 Book Results Next Results >

Do a full-text search for "antipsychotic agents"



Copyright © American Psychiatric Publishing, Inc. All Rights Reserved.
Copyright & Legal Disclaimer   Privacy Policy   Terms of Use
Silverchair